Clonal haematopoiesis of indeterminate ...
Document type :
Compte-rendu et recension critique d'ouvrage
PMID :
Permalink :
Title :
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)
Author(s) :
David, Clémence [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Duployez, Nicolas [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Eloy, Philippine [Auteur]
Université Paris Cité [UPCité]
Centre d'investigation Clinique [CHU Bichat] - Épidémiologie clinique [CIC 1425]
Belhadi, Drifa [Auteur]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Chezel, Julie [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Guern, Véronique Le [Auteur]
Service de médecine interne et centre de référence des maladies rares [CHU Cochin]
Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques [CRESS (U1153 / UMR_A 1125)]
Laouénan, Cédric [Auteur]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Fenwarth, Laurène [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Rouzaud, Diane [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Mathian, Alexis [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
de Almeida Chaves, Sébastien [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Duhaut, Pierre [Auteur]
CHU Amiens-Picardie
Mécanismes physiopathologiques et conséquences des calcifications cardiovasculaires - UR UPJV 7517 [MP3CV]
Fain, Olivier [Auteur]
CHU Saint-Antoine [AP-HP]
Galicier, Lionel [Auteur]
Hopital Saint-Louis [AP-HP] [AP-HP]
Ghillani-Dalbin, Pascale [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Kahn, Jean Emmanuel [Auteur]
Hôpital Ambroise Paré [AP-HP]
UFR Sciences de la santé Simone Veil [UVSQ Santé]
Morel, Nathalie [Auteur]
Service de médecine interne et centre de référence des maladies rares [CHU Cochin]
Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques [CRESS (U1153 / UMR_A 1125)]
Perard, Laurent [Auteur]
Centre hospitalier Saint Joseph - Saint Luc [Lyon]
Pha, Micheline [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Sarrot-Reynauld, Francoise [Auteur]
Hôpital Michallon
Aumaitre, Olivier [Auteur]
CHU Clermont-Ferrand
Chasset, François [Auteur]
CHU Tenon [AP-HP]
Limal, Nicolas [Auteur]
Hôpital Henri Mondor
Desmurs-Clavel, Helene [Auteur]
Hôpital Edouard Herriot [CHU - HCL]
Ackermann, Felix [Auteur]
Hôpital Foch [Suresnes]
Amoura, Zahir [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Papo, Thomas [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
Preudhomme, Claude [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Costedoat-Chalumeau, Nathalie [Auteur]
Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques [CRESS (U1153 / UMR_A 1125)]
Sacre, Karim [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Duployez, Nicolas [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Eloy, Philippine [Auteur]
Université Paris Cité [UPCité]
Centre d'investigation Clinique [CHU Bichat] - Épidémiologie clinique [CIC 1425]
Belhadi, Drifa [Auteur]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Chezel, Julie [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Guern, Véronique Le [Auteur]
Service de médecine interne et centre de référence des maladies rares [CHU Cochin]
Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques [CRESS (U1153 / UMR_A 1125)]
Laouénan, Cédric [Auteur]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Fenwarth, Laurène [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Rouzaud, Diane [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Mathian, Alexis [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
de Almeida Chaves, Sébastien [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Duhaut, Pierre [Auteur]
CHU Amiens-Picardie
Mécanismes physiopathologiques et conséquences des calcifications cardiovasculaires - UR UPJV 7517 [MP3CV]
Fain, Olivier [Auteur]
CHU Saint-Antoine [AP-HP]
Galicier, Lionel [Auteur]
Hopital Saint-Louis [AP-HP] [AP-HP]
Ghillani-Dalbin, Pascale [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Kahn, Jean Emmanuel [Auteur]
Hôpital Ambroise Paré [AP-HP]
UFR Sciences de la santé Simone Veil [UVSQ Santé]
Morel, Nathalie [Auteur]
Service de médecine interne et centre de référence des maladies rares [CHU Cochin]
Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques [CRESS (U1153 / UMR_A 1125)]
Perard, Laurent [Auteur]
Centre hospitalier Saint Joseph - Saint Luc [Lyon]
Pha, Micheline [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Sarrot-Reynauld, Francoise [Auteur]
Hôpital Michallon
Aumaitre, Olivier [Auteur]
CHU Clermont-Ferrand
Chasset, François [Auteur]
CHU Tenon [AP-HP]
Limal, Nicolas [Auteur]
Hôpital Henri Mondor
Desmurs-Clavel, Helene [Auteur]
Hôpital Edouard Herriot [CHU - HCL]
Ackermann, Felix [Auteur]
Hôpital Foch [Suresnes]
Amoura, Zahir [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Papo, Thomas [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
Preudhomme, Claude [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Costedoat-Chalumeau, Nathalie [Auteur]
Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques [CRESS (U1153 / UMR_A 1125)]
Sacre, Karim [Auteur]
Centre de recherche sur l'Inflammation [CRI (UMR_S_1149 / ERL_8252 / U1149)]
Journal title :
Rheumatology
Pages :
4355-4363
Publisher :
Oxford University Press (OUP)
Publication date :
2022-11-01
ISSN :
1462-0324
English keyword(s) :
Cardiovascular Diseases/complications
Lupus Erythematosus
Systemic/complications
cardiovascular events
clonal haematopoiesis of indeterminate potential
Clonal Hematopoiesis
Female
Hematopoiesis/genetics
Humans
Male
Retrospective Studies
Lupus Erythematosus
Systemic/complications
cardiovascular events
clonal haematopoiesis of indeterminate potential
Clonal Hematopoiesis
Female
Hematopoiesis/genetics
Humans
Male
Retrospective Studies
HAL domain(s) :
Sciences du Vivant [q-bio]/Médecine humaine et pathologie
English abstract : [en]
Abstract Objective The detection of somatic mutations among the genes of myeloid cells in asymptomatic patients—defining clonal haematopoiesis of indeterminate potential (CHIP)—is associated with a predisposition to ...
Show more >Abstract Objective The detection of somatic mutations among the genes of myeloid cells in asymptomatic patients—defining clonal haematopoiesis of indeterminate potential (CHIP)—is associated with a predisposition to cardiovascular events (CVEs) in the general population. We aimed to determine whether CHIP was associated with CVEs in SLE patients. Methods The study is an ancillary study of the randomized, double-blind, placebo-controlled, multicentre PLUS trial conducted from June 2007 through August 2010 at 37 centres in France, involving 573 SLE patients. The search for somatic mutations by high-throughput sequencing of 53 genes involved in clonal haematopoiesis was performed on genomic DNA collected at PLUS inclusion. CHIP prevalence was assessed in SLE and in a retrospective cohort of 479 patients free of haematological malignancy. The primary outcome was an incident CVE in SLE. Results Screening for CHIP was performed in 438 SLE patients [38 (29–47) years, 91.8% female]. Overall, 63 somatic mutations were identified in 47 patients, defining a CHIP prevalence of 10.7% in SLE. Most SLE patients (78.7%) carried a single mutation. Most variants (62.5%) were located in the DNMT3A gene. CHIP frequency was related to age and to age at SLE diagnosis, and was associated with a lower frequency of aPLs. CHIP occurred >20 years earlier (P < 0.00001) in SLE than in controls. The detection of CHIP at inclusion was not found to be associated with occurrence of CVEs during follow-up [HR = 0.42 (0.06–3.21), P = 0.406]. Conclusion The prevalence of CHIP is relatively high in SLE for a given age, but was not found to be associated with incident CVEs. Trial registration ClinicalTrials.gov, https://clinicaltrials.gov, NCT05146414.Show less >
Show more >Abstract Objective The detection of somatic mutations among the genes of myeloid cells in asymptomatic patients—defining clonal haematopoiesis of indeterminate potential (CHIP)—is associated with a predisposition to cardiovascular events (CVEs) in the general population. We aimed to determine whether CHIP was associated with CVEs in SLE patients. Methods The study is an ancillary study of the randomized, double-blind, placebo-controlled, multicentre PLUS trial conducted from June 2007 through August 2010 at 37 centres in France, involving 573 SLE patients. The search for somatic mutations by high-throughput sequencing of 53 genes involved in clonal haematopoiesis was performed on genomic DNA collected at PLUS inclusion. CHIP prevalence was assessed in SLE and in a retrospective cohort of 479 patients free of haematological malignancy. The primary outcome was an incident CVE in SLE. Results Screening for CHIP was performed in 438 SLE patients [38 (29–47) years, 91.8% female]. Overall, 63 somatic mutations were identified in 47 patients, defining a CHIP prevalence of 10.7% in SLE. Most SLE patients (78.7%) carried a single mutation. Most variants (62.5%) were located in the DNMT3A gene. CHIP frequency was related to age and to age at SLE diagnosis, and was associated with a lower frequency of aPLs. CHIP occurred >20 years earlier (P < 0.00001) in SLE than in controls. The detection of CHIP at inclusion was not found to be associated with occurrence of CVEs during follow-up [HR = 0.42 (0.06–3.21), P = 0.406]. Conclusion The prevalence of CHIP is relatively high in SLE for a given age, but was not found to be associated with incident CVEs. Trial registration ClinicalTrials.gov, https://clinicaltrials.gov, NCT05146414.Show less >
Language :
Anglais
Popular science :
Non
Source :
Submission date :
2024-02-17T03:38:17Z
Files
- document
- Open access
- Access the document
- Sacre%20CHIP%20SLE%20Rheumatology%20HAL.pdf
- Open access
- Access the document